 Connection
Matthew Greenhawt to Vaccines
This is a "connection" page, showing publications Matthew Greenhawt has written about Vaccines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.574 |
|
|
|
-
Lieberman JA, Chu DK, Ahmed T, Dribin TE, Abrams EM, Anagnostou A, Blumenthal KG, Boguniewicz M, Chase NM, Golden DBK, Hartog NL, Heimall JR, Ho T, Lawrence MG, Khan DA, Minniear TD, Mustafa SS, Oppenheimer JJ, Phillips EJ, Ramsey A, Rider NL, Schneider L, Shaker MS, Spergel JM, Stone CA, Stukus DR, Wang J, Greenhawt MJ. A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 2024 Sep; 133(3):286-294.
Score: 0.624
-
Greenhawt M, Shaker M. Reply to "Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines". J Allergy Clin Immunol Pract. 2023 02; 11(2):666-667.
Score: 0.568
-
Greenhawt M, Shaker M, Golden DBK, Abrams EM, Blumenthal KG, Wolfson AR, Stone CA, Krantz MS, Chu DK, Dwamena BA. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A?systematic review and meta-analysis. Allergy. 2023 01; 78(1):71-83.
Score: 0.561
-
Picard M, Stone CA, Greenhawt M. Management of patients with immediate reactions to COVID-19 vaccines. J Allergy Clin Immunol. 2023 02; 151(2):413-415.
Score: 0.553
-
Greenhawt M. True, true, and unrelated: Stop routine testing to vaccine excipients for suspected vaccine allergy. Ann Allergy Asthma Immunol. 2022 07; 129(1):24-26.
Score: 0.545
-
Greenhawt M, Abrams EM, Oppenheimer J, Vander Leek TK, Mack DP, Singer AG, Shaker M. The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract. 2021 04; 9(4):1438-1441.
Score: 0.495
-
Abrams EM, Greenhawt M, Shaker M, Kosowan L, Singer AG. Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada. Ann Allergy Asthma Immunol. 2021 10; 127(4):446-450.e1.
Score: 0.126
-
Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, Cox L, Khan D, Lang DM, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012 Jul; 130(1):25-43.
Score: 0.068
-
Gold MS, Amarasinghe A, Greenhawt M, Kelso JM, Kochhar S, Yu-Hor Thong B, Top KA, Turner PJ, Worm M, Law B. Anaphylaxis: Revision of the Brighton collaboration case definition. Vaccine. 2023 04 06; 41(15):2605-2614.
Score: 0.035
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|